Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4591 Efficacy of Trabectedin and Olaparib in homologous repair deficient neuroendocrine neoplasms – A subgroup analysis of the TOP-ART / PMO-1603 trial

Introduction: Genomic alterations resulting in homologous recombination deficiency (HRD) occur in a variety of cancers including neuroendocrine neoplasms (NEN). HRD-positive tumours are sensitive to PARP inhibitors such as olaparib. The DNA minor groove binder trabectedin leads to DNA double strand breaks and PARP activation. The combination of Trabectedin + Olaparib (TrO) may therefore have synergistic effects in HRD-positive tumours.

Conference:

Presenting Author: Apostolidis L

Authors: Apostolidis L, Ruebsam M, Teleanu M, Wagner S, Dorman K,

Keywords: Neuroendocrine Tumour, Neuroendocrine Carcinoma, targeted therapy, chemotherapy, HRD, olaparib, trabectedin, net, nec,

#4370 Role of 68GA-DOTATOC pet/ct in therapeutic decision-making for well-differentiated neuroendocrine tumours

Introduction: 68Ga-DOTATOC PET/CT is a highly sensitive and specific test for assessing gastroenteropancreatic and pulmonary neuroendocrine tumours (NET) expressing somatostatin receptors.

Conference:

Presenting Author: Cruz-Diaz W

Authors: Cruz Diaz W, Landaeta Kancev L, Martinez-Amores Martínez B, Bastidas Tamayo J, Estrella Santos A,

Keywords: 68Ga-DOTATOC PET/CT, well-differentiated, gastroenteropancreatic, pulmonary, neuroendocrine tumour, Lu-177-DOTATATE,

#4286 Clinicopathologic characteristics and survival outcomes in patients with gastroenteropancreatic neuroendocrine neoplasms at a Latin American reference centre

Introduction: Neuroendocrine neoplasms (NEN) have markedly increased over the past two decades. However, published data from Latin American countries remain scarce.

Conference:

Presenting Author: Cruz Diaz W

Authors: Cruz Diaz W, Paitan Amaro V, Haro Varas J, Macetas Núñez J, Leonardo Carbajal A,

Keywords: Well-differentiated, Gastroenteropancreatic neuroendocrine tumour, Retrospective study, overall survival,

#397 Swiss Neuroendocrine Tumor (SwissNET) Registry: Update After Three Years

Introduction: To improve epidemiological data on patients with neuroendocrine tumors (NETs) in Switzerland, the Swiss registry for NETs (SwissNET) was established in 2008. Here we present the current state of the registry in 2011.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Stettler C, Limacher A, Christ E, Wagner S, Pralong F,

Keywords: neuroendocrine tumors, registries, carcinoid tumor,

#170 Swiss Neuroendocrine Tumor (SwissNET) registry: Results after 30 Months

Introduction: The Swiss registry for NETs (SwissNET) was established in 2008 to improve epidemiological data on NET patients in Switzerland. Here the results after 30 months of follow-up are presented.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Stettler C, Allemann S, Christ E, Wagner S, Pralong F,

Keywords: neuroendocrine tumors, registries, carcinoid tumors ,